Is GlobalFoundries On The Verge Of A Breakout?
GLOBALFOUNDRIES Inc. (NASDAQ:GFS) is as a semiconductor foundry whose chips…
Buy
55
BHRB Quote, Financials, Valuation and Earnings
Last price:
$56.95
Seasonality move
:
2.17%
Day range:
$57.02 - $58.75
52-week range:
$46.00 - $75.32
Dividend yield:
3.79%
P/E ratio:
16.39x
P/S ratio:
2.63x
P/B ratio:
1.15x
Volume:
26.8K
Avg. volume:
36.7K
1-year change:
15.04%
Market cap:
$863.3M
Revenue:
$256.6M
EPS (TTM):
$3.51
Analysts' Opinion
-
Consensus RatingBurke & Herbert Financial Services has received a consensus rating of Buy. The company's average rating is a Buy based on 1 Buy rating, 0 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $69.50, Burke & Herbert Financial Services has an estimated upside of 20.81% from its current price of $57.53.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $69.00 representing 100% downside risk from its current price of $57.53.
Fair Value
-
According to the consensus of 1 analyst, Burke & Herbert Financial Services has 20.81% upside to fair value with a price target of $69.50 per share.
BHRB vs. S&P 500
-
Over the past 5 trading days, Burke & Herbert Financial Services has underperformed the S&P 500 by -2.02% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Burke & Herbert Financial Services does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Burke & Herbert Financial Services has grown year-over-year revenues for 4 quarters straight. In the most recent quarter Burke & Herbert Financial Services reported revenues of $81.9M.
Earnings Growth
-
Burke & Herbert Financial Services has grown year-over-year earnings for 3 quarters straight. In the most recent quarter Burke & Herbert Financial Services reported earnings per share of $1.80.
Enterprise value:
-298.8M
EV / Invested capital:
-0.26x
Price / LTM sales:
2.63x
EV / EBIT:
-1.31x
EV / Revenue:
-0.96x
PEG ratio (5yr expected):
0.56x
EV / Free cash flow:
-2.68x
Price / Operating cash flow:
7.38x
Enterprise value / EBITDA:
--
Gross Profit (TTM):
--
Return On Assets:
0.82%
Net Income Margin (TTM):
18.46%
Return On Equity:
8.91%
Return On Invested Capital:
5.43%
Operating Margin:
--
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Income Statement | ||||||
| Revenue | $119.5M | $106.4M | $312.6M | $25.8M | $81.9M | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Operating Income | -- | -- | -- | -- | -- | |
| EBITDA | -- | -- | -- | -- | -- | |
| Diluted EPS | $5.60 | $2.71 | $3.51 | $0.69 | $1.80 | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | -- | -- | $1.5B | $1.3B | $1.6B | |
| Total Assets | -- | -- | $3.7B | $3.7B | $7.8B | |
| Current Liabilities | -- | -- | -- | $360M | $300M | |
| Total Liabilities | -- | -- | $3.4B | $3.4B | $7.1B | |
| Total Equity | -- | -- | $289.8M | $319.3M | $758M | |
| Total Debt | -- | -- | $321.7M | $360M | $413.3M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $57.8M | $38.7M | $116.4M | $7.1M | $37.6M | |
| Cash From Investing | -$140.2M | -$82.8M | $216.8M | -$70.6M | $22.6M | |
| Cash From Financing | $139.7M | -$18.7M | -$238.4M | $73.1M | -$46.7M | |
| Free Cash Flow | $32.2M | $25.6M | $111.5M | $5.6M | $35.9M | |
BHRB
Sector
Market Cap
$863.3M
$628.1M
Price % of 52-Week High
76.38%
87.3%
Dividend Yield
3.79%
1.97%
Shareholder Yield
0.19%
4.02%
1-Year Price Total Return
15.04%
9.14%
Beta (5-Year)
0.181
0.587
Dividend yield:
3.79%
Annualized payout:
$2.14
Payout ratio:
57.47%
Growth streak:
1 years
Technicals
8-day SMA
Sell
Level
$57.90
200-day SMA
Sell
Level
$61.67
Bollinger Bands (100)
Sell
Level
54.06 - 63.28
Chaikin Money Flow
Sell
Level
-3M
20-day SMA
Buy
Level
$56.12
Relative Strength Index (RSI14)
Buy
Level
56.41
ADX Line
Buy
Level
30.78
Williams %R
Neutral
Level
-48.9786
50-day SMA
Buy
Level
$55.06
MACD (12, 26)
Buy
Level
1.09
25-day Aroon Oscillator
Buy
Level
60
On Balance Volume
Sell
Level
-1.2M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (0.2878)
Sell
CA Score
(Annual)
Level (-2.182)
--
Beneish M-Score
(Annual)
Level (--)
Sell
Momentum Score
Level (6)
Sell
Ohlson Score
Level (2.0884)
--
Piotroski F Score
(Annual)
Level (--)
--
Quality Ratio Score
Level (--)
Sell
Fundamental Score
Level (6)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Burke & Herbert Financial Services Corp is the bank holding company. Through its subsidiary, it predominantly serves small to medium-sized businesses, their owners and employees, professional corporations, non-profits, and individuals with various banking products and financial services. Some of its products and service offerings include checking, savings, and money market accounts, certificates of deposit, treasury and cash management services, commercial and industrial loans, commercial real estate loans, residential mortgage, acquisition, construction, and development loans, online banking, mobile banking, and wealth and trust services. The company operates in a single segment, namely Community Banking.
Stock Forecast FAQ
In the current month, BHRB has received 1 Buy ratings 0 Hold ratings, and 0 Sell ratings. The BHRB average analyst price target in the past 3 months is $69.50.
-
Where Will Burke & Herbert Financial Services Stock Be In 1 Year?
According to analysts, the consensus estimate is that Burke & Herbert Financial Services share price will rise to $69.50 per share over the next 12 months.
-
What Do Analysts Say About Burke & Herbert Financial Services?
Analysts are divided on their view about Burke & Herbert Financial Services share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Burke & Herbert Financial Services is a Sell and believe this share price will drop from its current level to $69.00.
-
What Is Burke & Herbert Financial Services's Price Target?
The price target for Burke & Herbert Financial Services over the next 1-year time period is forecast to be $69.50 according to 1 Wall Street analyst, 1 of them rates the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is BHRB A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Burke & Herbert Financial Services is a Buy. 1 of 1 analysts rates the stock a Buy at this time.
-
How Can I Buy Shares Of BHRB?
You can purchase shares of Burke & Herbert Financial Services via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Burke & Herbert Financial Services shares.
-
What Is The Burke & Herbert Financial Services Share Price Today?
Burke & Herbert Financial Services was last trading at $56.95 per share. This represents the most recent stock quote for Burke & Herbert Financial Services. Yesterday, Burke & Herbert Financial Services closed at $57.53 per share.
-
How To Buy Burke & Herbert Financial Services Stock Online?
In order to purchase Burke & Herbert Financial Services stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Dick’s Sporting Goods Buying Foot Locker Smart?
Last week, Dick’s Sporting Goods (NYSE:DKS) announced that it would…
Is Ginkgo Bioworks Stock a Good Buy?
Biotech innovator Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) has had better…
Stock Ideas
Buy
70
Is MSFT Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 39x
Buy
71
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 46x
Sell
43
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 34x
Alerts
Buy
55
RGC alert for May 21
Regencell Bioscience Holdings [RGC] is down 5.46% over the past day.
Buy
64
AKRO alert for May 21
Akero Therapeutics [AKRO] is up 0.36% over the past day.
Buy
76
AGYS alert for May 21
Agilysys [AGYS] is down 0.47% over the past day.
